AP9400647A0 - Medicaments for use in treatment of HIV or cancer patients. - Google Patents

Medicaments for use in treatment of HIV or cancer patients.

Info

Publication number: AP9400647A0
Authority: AP; ARIPO
Prior art keywords: treatment; medicaments; hiv; cancer patients; group substituent
Prior art date: 1993-05-21

Application number

APAP/P/1994/000647A

Other languages

English (en)

Inventor

Ayuko Washington Odur Dr

Original Assignee

Radopath Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-21

Filing date

1994-05-20

Publication date

1995-11-20

1993-05-21 Priority claimed from GB939310520A external-priority patent/GB9310520D0/en

1994-05-20 Application filed by Radopath Ltd filed Critical Radopath Ltd

1995-11-20 Publication of AP9400647A0 publication Critical patent/AP9400647A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/24—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having three, and only three, nitro groups bound to the ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/39—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing halogen atoms bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/40—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitro or nitroso groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/46—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/70—Monocarboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Immunology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)

APAP/P/1994/000647A 1993-05-21 1994-05-20 Medicaments for use in treatment of HIV or cancer patients. AP9400647A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939310520A GB9310520D0 (en)	1993-05-21	1993-05-21	Arylating agents
GB9405292A GB9405292D0 (en)	1993-05-21	1994-03-17	Arylating agents

Publications (1)

Publication Number	Publication Date
AP9400647A0 true AP9400647A0 (en)	1995-11-20

Family

ID=26302926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/1994/000647A AP9400647A0 (en)	1993-05-21	1994-05-20	Medicaments for use in treatment of HIV or cancer patients.

Country Status (18)

Country	Link
EP (1)	EP0700287A1 (fr)
JP (1)	JPH08510468A (fr)
CN (1)	CN1124012A (fr)
AP (1)	AP9400647A0 (fr)
AU (1)	AU6729794A (fr)
BG (1)	BG100242A (fr)
BR (1)	BR9406548A (fr)
CA (1)	CA2163459A1 (fr)
CZ (1)	CZ307395A3 (fr)
DZ (1)	DZ1781A1 (fr)
FI (1)	FI955605L (fr)
HU (1)	HUT77764A (fr)
IL (1)	IL109712A0 (fr)
MA (1)	MA23202A1 (fr)
NO (1)	NO954702L (fr)
OA (1)	OA10196A (fr)
SK (1)	SK145795A3 (fr)
WO (1)	WO1994027584A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE198273T1 (de) *	1994-03-17	2001-01-15	Radopath Pharmaceuticals Inter	Wirkstof gegen viren und krebs
GB2303790A (en) *	1994-03-17	1997-03-05	Radopath Ltd	Benzoic acid containing chloro and or nitro groups for cancer or viral therapy
WO1996029067A1 (fr) *	1995-03-17	1996-09-26	Radopath Limited	Agents antiviraux et anticancereux
ATE253902T1 (de) *	1995-03-30	2003-11-15	Werner Prof Dr Kreutz	Arzneistoffe zur selektiven bekämpfung von tumorgewebe
US5756548A (en) *	1995-04-03	1998-05-26	Centaur Pharmaceuticals, Inc.	Acetamidobenzamide compounds for neurodegenerative disorders
GB9615619D0 (en) *	1996-03-18	1996-09-04	Radopath Ltd	Costimulation of TcR/CD3-induced T-Lymphocytes
US5955506A (en) *	1996-04-03	1999-09-21	Centaur Pharmaceuticals, Inc.	Benzamides for neurodegenerative disorder treatment
NZ565654A (en)	2005-07-18	2010-10-29	Bipar Sciences Inc	Use of iodonitrobenzamide compounds for the treatment of ovarian cancer
WO2008030883A2 (fr)	2006-09-05	2008-03-13	Bipar Sciences, Inc.	Traitement du cancer
JP2011503111A (ja) *	2007-11-12	2011-01-27	バイパーサイエンシズ，インコーポレイティド	Ｐａｒｐ阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1283331A (en) *	1970-01-03	1972-07-26	Smith Kline French Lab	Pharmaceutical compositions
US3978119A (en) *	1975-07-11	1976-08-31	Gulf Research & Development Company	Process for converting stilbene or bibenzyl to nitrobenzoic acids
US4283421A (en) *	1979-12-19	1981-08-11	Ray Frank F	Anti-viral treatment
US4277492A (en) *	1980-05-21	1981-07-07	The Dow Chemical Company	Novel 4-bis((Phenylmethyl)amino)-benzenesulfonic acids possessing antiviral activity
US4762705A (en) *	1981-11-10	1988-08-09	Adolf W. Schwimmer	Cancer therapy with interferon
CA1262864A (fr) *	1982-09-17	1989-11-14	Clarence D. Cone	Methode de production d'une oncolyse
US4935450A (en) *	1982-09-17	1990-06-19	Therapeutical Systems Corporation	Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60224619A (ja) *	1984-04-24	1985-11-09	Adeka Argus Chem Co Ltd	放射線増感剤
RO92333B1 (ro) *	1985-06-18	1987-09-01	Institutul De Cercetari Chimico-Farmaceutice	Produs radiosensibilizator al celulelor tumorale
JPS6468315A (en) *	1987-09-09	1989-03-14	Yasuo Kawasaki	Antipyrotic of picric acid (2,4,6-trinitrophenol)
DE69124223T2 (de) *	1990-02-05	1997-04-30	Lifescience Corp	Vitamine und mineralien enthaltende nahrungszusätze
CA2036695A1 (fr) *	1990-03-01	1991-09-02	Brian Gregory Chapman	Systeme d'imagerie ponctuelle avec poste de production associe
EP0524212A1 (fr) *	1990-04-03	1993-01-27	Radopath Limited	Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
GB9103075D0 (en) *	1991-02-13	1991-03-27	Washington Odur Ayuko	Trinitrobenzene derivatives and their therapeutic use
US5422277A (en) *	1992-03-27	1995-06-06	Ortho Diagnostic Systems Inc.	Cell fixative composition and method of staining cells without destroying the cell surface

1994
- 1994-05-18 DZ DZ940047A patent/DZ1781A1/fr active
- 1994-05-20 AP APAP/P/1994/000647A patent/AP9400647A0/en unknown
- 1994-05-20 MA MA23512A patent/MA23202A1/fr unknown
- 1994-05-22 IL IL10971294A patent/IL109712A0/xx unknown
- 1994-05-23 CA CA002163459A patent/CA2163459A1/fr not_active Abandoned
- 1994-05-23 CZ CZ953073A patent/CZ307395A3/cs unknown
- 1994-05-23 CN CN94192181A patent/CN1124012A/zh active Pending
- 1994-05-23 WO PCT/GB1994/001126 patent/WO1994027584A2/fr not_active Ceased
- 1994-05-23 SK SK1457-95A patent/SK145795A3/sk unknown
- 1994-05-23 BR BR9406548A patent/BR9406548A/pt not_active Application Discontinuation
- 1994-05-23 EP EP94915671A patent/EP0700287A1/fr not_active Ceased
- 1994-05-23 HU HU9503327A patent/HUT77764A/hu unknown
- 1994-05-23 FI FI955605A patent/FI955605L/fi not_active Application Discontinuation
- 1994-05-23 JP JP7500384A patent/JPH08510468A/ja active Pending
- 1994-05-23 AU AU67297/94A patent/AU6729794A/en not_active Abandoned
1995
- 1995-11-21 OA OA60743A patent/OA10196A/en unknown
- 1995-11-21 NO NO954702A patent/NO954702L/no unknown
- 1995-12-21 BG BG100242A patent/BG100242A/bg unknown

Also Published As

Publication number	Publication date
FI955605A7 (fi)	1996-01-22
JPH08510468A (ja)	1996-11-05
OA10196A (en)	1996-12-18
HUT77764A (hu)	1998-08-28
FI955605A0 (fi)	1995-11-21
BR9406548A (pt)	1996-01-02
MA23202A1 (fr)	1994-12-31
FI955605L (fi)	1996-01-22
AU6729794A (en)	1994-12-20
DZ1781A1 (fr)	2002-02-17
IL109712A0 (en)	1994-08-26
NO954702L (no)	1996-01-22
BG100242A (bg)	1996-07-31
HU9503327D0 (en)	1996-01-29
CN1124012A (zh)	1996-06-05
EP0700287A1 (fr)	1996-03-13
WO1994027584A2 (fr)	1994-12-08
WO1994027584A3 (fr)	1995-05-26
SK145795A3 (en)	1996-10-02
CZ307395A3 (en)	1996-06-12
CA2163459A1 (fr)	1994-12-08
NO954702D0 (no)	1995-11-21

Publication	Publication Date	Title
IL143512A (en)	2013-06-27	Azabicycloalkanes, pharmaceuticals including them and their use in the manufacture of drugs for the prevention or treatment of infection by the immunodeficiency virus
ES2058892T3 (es)	1994-11-01	Uso de omeprazol como agente antimicrobiano.
NZ334124A (en)	2000-10-27	Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
AU2001248331A1 (en)	2001-09-24	Medicaments against viral diseases
BG101118A (en)	1998-04-30	Therapeutical compounds
BR0008840A (pt)	2002-01-08	Derivados de camptotecina tendo atividade antitumoral
AU2002236765A1 (en)	2002-07-30	Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
KR970702705A (ko)	1997-06-10	수술도구 운반, 조종 및 추출을 위한 의료형 선형 액추에이터(medical linear actuator for surgical delivery. manuipulation. and extraction)
FR2710915B1 (fr)	1995-11-24	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
AU2005099A (en)	1999-07-12	Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
AU4170197A (en)	1998-03-19	Pharmaceutical compounds
AP9400647A0 (en)	1995-11-20	Medicaments for use in treatment of HIV or cancer patients.
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
AU4445089A (en)	1990-05-17	Lactamimides in the treatment of drug-resistant protozoal infections
BG104179A (en)	2000-10-31	Phanquinon administration for the treatment of the alzheimer's disease
AU3401093A (en)	1993-09-09	Therapeutic agent for threatened abortion
MX9403032A (es)	1995-01-31	Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
CA2248794A1 (fr)	1997-10-16	Medicaments pour la prevention et le traitement d'infections virales
AU6309398A (en)	1998-10-12	Agent for preventing and/or treating cachexia
NO984651L (no)	1998-12-03	Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ES2113549T3 (es)	1998-05-01	Metodo para inhibir la replicacion de vih empleando il-4.
ES2184121T3 (es)	2003-04-01	Formulacion para el tratamiento y/o profilaxis de la demencia.
FI965196A7 (fi)	1996-12-23	HIV-infektion yhdistelmähoito
GB9207798D0 (en)	1992-05-27	Complexes of poladenylic acid polyuridylic acid